Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dallas, TX - December 19, 2018 "KALY has entered into a joint venture agreement named US Cannabis Health with Puration, Inc. (USOTC: PURA), and Nouveau Pharmaceuticals, Inc. (USOTC: NOUV) to combine their respective resources for the specific purpose of developing partnerships with major pharmaceutical companies to produce medical cannabis therapies...Finally, I think the developing partnership between KALY and its other US Cannabis Health partners with Generex can put KALY, its other US Cannabis Health partners and Generex on top of their respective markets.”
https://ih.advfn.com/stock-market/USOTC/kali-inc-KALY/stock-news/78920784/kali-extracts-releases-preclinical-research-study
"Management plans to release an online presentation this Thursday, December, 20th, 2018 to update shareholders...to include exciting updates with the recent spinoff of PURA’s cannabis cultivation operation to NOUV."
https://ih.advfn.com/stock-market/USOTC/puration-inc-pc-PURA/stock-news/78901355/pura-puration-inc-cannabis-beverage-business-boo
IMHO, i believe it is from investors keeping it down and scare tactics for the uninformed to sell because accumulation is off the charts. when this moves, 3's and 4's will go quicker than before.
December 12, 2018 - USMJ CEO Believes Media Missing Majority Of 2018 Farm Act Potential - PURA KALY and Rest of USMJ Family Prepare For More
December 12, 2018 -- InvestorsHub NewsWire -- North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) CEO and Chairman, Steven Rash, today reacted to recent news following the U.S. Senate’s approval of the 2018 Farm Act including the legalization of hemp farming. Mr. Rash believes the media is missing the lion’s share of the opportunity generated by the legalization of hemp. Articles, such as, Barron’s “CBD Will Get a Boost With Passage of a New Farm Bill” are focused primarily on the CBD market alone and missing the multitude of applications of legal hemp beyond CBD. USMJ’s family of companies includes Puration (USOTC: PURA), Priority Aviation, (USOTC: PJET), Nouveau (USOTC: NOUV), and Kali, (USOTC: KALY). Mr. Rash presents PURA and KALY as leaders in the hemp-derived CBD market, both positioned to benefit from the CBD opportunity the media is recognizing, but that the two companies along with USMJ, NOUV and PJET have even more to offer than hemp-derived CBD. Mr. Rash recently published a letter to shareholders of the USMJ family of companies addressing the overall opportunity generated by the what appears to be the imminent passage of the 2018 Farm Act to include the legalization of hemp farming. In reaction to the news, USMJ has released Mr. Rash’s letter again in an effort to expand consideration of the coming legalization of hemp farming beyond hemp-derived CBD. His letter is included in its entirety below.
Dear Legal Cannabis Industry Enthusiasts –
Some of you are enthusiast because you enjoy cannabis recreationally, legal or not, and strongly believe the prohibition of cannabis is ridiculous and should be rescinded. Others of you are investment enthusiasts and are attracted to the explosive return-on-investment (ROI) opportunity. Some of you, like myself, are advocates for the industry because cannabis, in one shape form or another, has medicinally helped someone you care about. And still others are enthusiastic about the multitude of benefits to our economy and the environment that can be realized through the legalization of hemp farming in the United States. We are imminently approaching a landmark event, not just in the history of cannabis, but in global economics. All factors seem to be aligned for the pending 2018 Farm Act to include the legalization of hemp farming.
The legalization of hemp farming will bring a sweeping and comprehensive impact to numerous industries to include farming, pharmaceuticals, construction, and energy – to name only a very few. The economy and the environment have been robbed of the benefits from hemp for nearly a century and a massive void is about to be filled. Hemp is a superior source of raw materials for construction, clothing, and paper manufacturing. Hemp fiber can be used in microprocessors and supercapacitors. Hemp grows vigorously with little water and without the need for chemical fertilizers and pesticides. The underlying economic benefits are huge.
The following is what a recently Motley Fool article had to say about the potential of the legalization of hemp. "If the bill makes it through Congress and is signed by President Trump, as widely expected, industrial hemp should be legal on Jan. 1, 2019. If this occurs, the U.S. market for hemp -- and its derivatives -- is expected to soar. The hemp-derived CBD market is projected to rocket from about $591 million this year to $22 billion by 2022, according to the Brightfield Group. That's a whopping 37-fold increase in just four years!"
Keep in mind, Motley Fool is just concentrating here on hemp-derived CBD. They haven’t touched on the plethora of other hemp applications, let alone the benefit to the environment. In other words, the legalization of hemp is even bigger than how big Motely Fool indicates it to be.
When we started USMJ back in 2013, we did so with a spirit of an entrepreneurial explorer. We felt the industry had no predetermined answers in regard to what products consumers would want or what the value chain might look like that produced those products. We’ve experimented with far more production and product applications than those we have brought to market. We have more ongoing enterprise experiments in the works than any shareholder knows about today. The products and processes that the USMJ family of companies has brought to market have been thoroughly vetted and now lead within their niche segment. The USMJ brand name stands out in the cannabis industry. That brand name will soon be the center of a major cannabis sector ecommerce site. USMJ developed and spun off what is today Puration (PURA), the leading producer of a hemp-derived CBD infused sports beverage called EVERx. The work with EVERx advance a patented cannabis extraction process which is today housed under the company Kali-Extracts (KALY). In an effort to develop high-quality cannabis for extraction and infusion, we built or own cultivation operation working today on the development of a proprietary cultivar. The cannabis cultivation operation is housed under Nouveau (NOUV). One of my favorite projects has been the AmeriCanna Cafe. I enjoy the retail interface and the opportunity to hear from the cannabis community first hand. The AmeriCanna Cafe concept restaurant is now housed under the public entity, Priority Aviation (PJET) and yes, we plan to change the name of the public holding company. The majority interest positions in USMJ, PURA, NOUV, and PJET are all held by ACI Conglomerated. ACI stands for American Cannabis Innovations and in addition to being the CEO and Chairman of USMJ, I am also the CEO and Chairman of ACI Conglomerated. The original owner of the cannabis extraction patent, through his company NCM Biotech, is an individual named Frederick Ferri. We have been working with Fred for years even before the merger of NCM Biotech into KALY. PURA has the sole license of the patent and we consider, Fred and KALY part of the family. We formalized our relationship with Fred and KALY through the US Cannabis Health joint venture between PURA, NOUV and KALI where the three companies are working together to forge partnerships with pharmaceutical companies and with the pharmaceutical partnership, produce new pharmaceutical products that include cannabis concentrates.
Through our ongoing spirit of entrepreneurial exploration in the cannabis sector now founded on years of experience through trial and error, the USMJ family of companies, to include PURA, NOUV, PJET and KALY are poised to capitalize on the imminent legalization of hemp farming with the pending passage of the 2018 Farm Act. I strongly believe all five companies are leaders in their own cannabis sector niche: USMJ in becoming the Amazon of cannabis with the pending launch of its online, ecommerce site; PURA with is cannabis infused beverage business; NOUV with its cannabis cultivation business; PJET with the AmeriCanna Cafe and KALY with its patented cannabis extraction business. I anticipate the legalization of hemp will enhance the valuation of all five companies and in so doing, dramatically improve their access to resources to support even greater accelerated growth than they have already exhibited.
In closing I will reiterate and emphasize that I believe the legalization of hemp farming as anticipated under the pending 2018 Farm Act, is the single biggest event yet to date to take place in the developing and evolving legal cannabis sector. The legalization of hemp is a far bigger even than the legalization of recreational marijuana in Canada. The size of the hemp market dwarfs the size of the recreational marijuana market, and the size of the United States market overall, dwarfs the size of the Canadian market. I think the legalization of hemp as expected under the 2018 Farm Act is great for the entire market of entrepreneurial cannabis enterprises in the United States and I would hold out any of the USMJ family of companies, with their combined experiences, expertise and living spirit of entrepreneurial leadership, as a standout in the coming new era of the cannabis sector where hemp farming is now legal.
Here is to the happiest of holidays for all of us enthusiastic about a world where cannabis is legal for all; We couldn’t ask for a much better gift than a Farm Act that legalizes hemp farming.
Steven Rash
CEO and Chairman
USMJ and ACI Conglomerated
www.growusmj.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Steven Rash
CEO North American Cannabis Holdings, Inc.
info@aciconglomerated.com
+1-800-861-1350
NEWS!!! December 10, 2018
USMJ Family of Companies Anticipate Dramatic Growth with Legalized Hemp Farming
Dallas, TX. -- December 10, 2018 -- InvestorsHub NewsWire -- North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) today released a letter from its CEO and Chairman discussing the potential for the overall cannabis industry to be realized from the 2018 Farm Act that includes, as drafted, the legalization of hemp farming. The letter is intended for all with an interest in the U.S. cannabis industry and specifically for those invested in any of the USMJ family of companies. Steven Rash, CEO and Chairman of USMJ is also one of its founders. USMJ entered the U.S. cannabis sector in 2013 with an entrepreneurial strategy to explore and investigate cannabis enterprise opportunities. Over the last five years, that entrepreneurial strategy has turned into five public companies, one very profitable dividend payout, two pending dividend payouts, a leading CBD infused beverage, a concept cannabis themed restaurant, a recognized cannabis industry brand name (USMJ), a patent for cannabis extraction, a revenue producing facility for cannabis cultivation, and over a dozen additional incubating cannabis enterprise ventures. The shareholders of USMJ as well as the shareholders of Puration (USOTC: PURA), Priority Aviation, (USOTC: PJET), Nouveau (USOTC: NOUV), and Kali, (USOTC: KALY) will be particularly interested in Mr. Rash’s letter. His letter is included in its entirety below.
Some of you are enthusiast because you enjoy cannabis recreationally, legal or not, and strongly believe the prohibition of cannabis is ridiculous and should be rescinded. Others of you are investment enthusiasts and are attracted to the explosive return-on-investment (ROI) opportunity. Some of you, like myself, are advocates for the industry because cannabis, in one shape of form or another, has medicinally helped someone you care about. And still others are enthusiastic about the multitude of benefits to our economy and the environment that can be realized through the legalization of hemp farming in the United States. We are imminently approaching a landmark event, not just in the history of cannabis, but in global economics. All factors seem to be aligned for the pending 2018 Farm Act to include the legalization of hemp farming.
The legalization of hemp farming will bring a sweeping and comprehensive impact to numerous industries to include farming, pharmaceuticals, construction, and energy – to name only a very few. The economy and the environment have been robbed of the benefits from hemp for nearly a century and a massive void is about to be filled. Hemp is a superior source of raw materials for construction, clothing, and paper manufacturing. Hemp fiber can be used in microprocessors and supercapacitors. Hemp grows vigorously with little water and without the need for chemical fertilizers and pesticides. The underlying economic benefits are huge.
The following is what a recent Motley Fool article had to say about the potential of the legalization of hemp. "If the bill makes it through Congress and is signed by President Trump, as widely expected, industrial hemp should be legal on Jan. 1, 2019. If this occurs, the U.S. market for hemp -- and its derivatives -- is expected to soar. The hemp-derived CBD market is projected to rocket from about $591 million this year to $22 billion by 2022, according to the Brightfield Group. That's a whopping 37-fold increase in just four years!"
Keep in mind, Motley Fool is just concentrating here on hemp-derived CBD. They haven’t touched on the plethora of other hemp applications, let alone the benefit to the environment. In other words, the legalization of hemp is even bigger than how big Motely Fool indicates it to be.
When we started USMJ back in 2013, we did so with a spirit of an entrepreneurial explorer. We felt the industry had no predetermined answers in regard to what products consumers would want or what the value chain might look like that produced those products. We’ve experimented with far more production applications and product opportunies than those we have currently brought to market. We have more ongoing enterprise experiments in the works than any shareholder knows about today. The products and processes that the USMJ family of companies has brought to market have been thoroughly vetted and now lead within their niche segment. The USMJ brand name stands out in the cannabis industry. That brand name will soon be the center of a major cannabis sector ecommerce site. USMJ developed and spun off what is today Puration (PURA), the leading producer of a hemp-derived CBD infused sports beverage called EVERx. The work with EVERx advanced by a patented cannabis extraction process which is today housed under the company Kali-Extracts (KALY). In an effort to develop high-quality cannabis for extraction and infusion, we built or own cultivation operation working today on the development of a proprietary cultivar. The cannabis cultivation operation is housed under Nouveau (NOUV). One of my favorite projects has been the AmeriCanna Cafe. I enjoy the retail interface and the opportunity to hear from the cannabis community first hand. The AmeriCanna Cafe concept restaurant is now housed under the public entity, Priority Aviation (PJET) and yes, we plan to change the name of the public holding company. The majority interest positions in USMJ, PURA, NOUV, and PJET are all held by ACI Conglomerated. ACI stands for American Cannabis Innovations and in addition to being the CEO and Chairman of USMJ, I am also the CEO and Chairman of ACI Conglomerated. The original owner of the cannabis extraction patent, through his company NCM Biotech, is an individual named Frederick Ferri. We have been working with Fred for years even before the merger of NCM Biotech into KALY. PURA has the sole license of the patent and we consider, Fred and KALY part of the family. We formalized our relationship with Fred and KALY through the US Cannabis Health joint venture between PURA, NOUV and KALI where the three companies are working together to forge partnerships with pharmaceutical companies and with the pharmaceutical partnership, produce new pharmaceutical products that include cannabis concentrates.
Through our ongoing spirit of entrepreneurial exploration in the cannabis sector now founded on years of experience through trial and error, the USMJ family of companies, to include PURA, NOUV, PJET and KALY are poised to capitalize on the imminent legalization of hemp farming with the pending passage of the 2018 Farm Act. I strongly believe all five companies are leaders in their own cannabis sector niche: USMJ in becoming the Amazon of cannabis with the pending launch of its online, ecommerce site; PURA with is cannabis infused beverage business; NOUV with its cannabis cultivation business; PJET with the AmeriCanna Cafe and KALY with its patented cannabis extraction business. I anticipate the legalization of hemp will enhance the valuation of all five companies and in so doing, dramatically improve their access to resources to support even greater accelerated growth than they have already exhibited.
In closing I will reiterate and emphasize that I believe the legalization of hemp farming as anticipated under the pending 2018 Farm Act, is the single biggest event yet to date to take place in the developing and evolving legal cannabis sector. The legalization of hemp is a far bigger event than the legalization of recreational marijuana in Canada. The size of the hemp market dwarfs the size of the recreational marijuana market, and the size of the United States market overall, dwarfs the size of the Canadian market. I think the legalization of hemp as expected under the 2018 Farm Act is great for the entire market of entrepreneurial cannabis enterprises in the United States and I would hold out any of the USMJ family of companies, with their combined experiences, expertise and living spirit of entrepreneurial leadership, as a standout in the coming new era of the cannabis sector where hemp farming is now legal.
Here is to the happiest of holidays for all of us enthusiastic about a world where cannabis is legal for all; We couldn’t ask for a much better gift than a Farm Act that legalizes hemp farming.
Steven Rash
CEO and Chairman
USMJ and ACI Conglomerated
www.growusmj.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Steven Rash
CEO North American Cannabis Holdings, Inc.
info@aciconglomerated.com
+1-800-861-1350
PR First Released Friday, December 7, 2018 – See Source
"The Amazon of Cannabis"
US Cannabis Health CEO is Steven Rash. He is also the CEO of USMJ. USMJ is part of the ACI Comglomerate, it is possible that USMJ may be the "other" company as well.
The Amazon of Cannabis
From my earlier post of EVSV in conversation with NOUV possible...
"...Among other ongoing developments, the company (EVSV) is in conversations to engaged in a joint venture with a cannabis cultivation operation working to develop a proprietary hemp cultivar."
https://ih.advfn.com/p.php?pid=nmona&article=78708901
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144934751
Kali-Extracts and Puration, with two other partners (NOUV & ?), have together formed a joint venture company (JV) titled US Cannabis Health. The purpose of the JV is to pursue partnerships with pharmaceutical companies to produce cannabis extract pharmaceutical applications. The JV has recently signed its first agreement, and in conjunction with that agreement, Puration will produce private labeled hemp-derived CBD infused water under the client pharmaceutical company’s name. Puration has engaged Kali-Extracts to make a custom hemp-derived CBD extract specific to the requirements for the private labeled hemp-derived CBD water Puration will produce for the pharmaceutical company.
within the PR, it mentions "with two other partners", we know that originally, it was NOUV, PURA, and Kaly. i wonder who is the other one.
https://ih.advfn.com/stock-market/USOTC/kali-inc-KALY/stock-news/78853509/kali-extracts-inc-announces-300-000-contract-to-p
"NOUV has already made substantial progress toward resolving its current financial reporting delinquency. NOUV anticipates having its financial reporting current within the next two weeks...NOUV plans to keep NOUV and PURA shareholders up to date on the stock dividend process, in addition to updating shareholders on the new post cannabis cultivation business acquisition plans from a new corporate website anticipated to launch next week. With the updated website, NOUV's communication contact information will also be updated."
https://www.otcmarkets.com/stock/PURA/news/Puration-Inc-Announces-15-Nouveau-Stock-Dividend-Declaration?id=210493
Once NOUV becomes current, then and only then, will NOUV be able to file with FINRA to affect the declared reverse split and stock dividend.
i don't know but under Generex's umbrella would be a great place to be.
Acquisition Possible...
"The agreement with Puration is an initial step in the development of a larger and more comprehensive strategy where Generex is exploring the possible acquisition of US Cannabis Health, a joint venture company that includes Puration’s participation with other innovators in the pursuit of developing new cannabinoid therapies...With our US Cannabis Health partners, we are confident in the potential of the new extracts to meet and exceed Generex’s expectations."
https://ih.advfn.com/p.php?pid=nmona&article=78757650
“With our US Cannabis Health partners, we are confident in the potential of the new extracts to meet and exceed Generex’s expectations."
https://ih.advfn.com/p.php?pid=nmona&article=78756955
NOUV is the backbone to the entire operation as the cultivator for all companies involved. Good times ahead.
Agree. NOUV is mentioned in all of their PR's. It is as if management is hinting to investors...load up before we release news/PR.
NOUV may cultivate for EVSV as well
Enviro-Serv Inc To Roll Out 2019 Hemp Farming Services Plan At Southern US Hemp Conference and Expo
"EVSV is bringing its expertise in organic fertilizers and other cultivation services to the industrial hemp farming market. Among other ongoing developments, the company is in conversations to engaged in a joint venture with a cannabis cultivation operation working to develop a proprietary hemp cultivar."
https://ih.advfn.com/p.php?pid=nmona&article=78708901
"Nouveau has recently acquired a cannabis cultivation operation from Puration. In the JV, Nouveau would be tasked with developing a proprietary pharmaceutical grade hemp cultivar. The acquired cannabis cultivation has already initiated efforts toward developing a proprietary, pharmaceutical grade hemp cultivar."
https://finance.yahoo.com/news/kali-inc-announces-us-cannabis-155428738.html
NOUV management is saving the best for last. the other companies are very forthcoming with news/PR, i believe that NOUV will be the same. once NOUV is cleaned up...filings, news/PR, name change, and ticker change will occur. the dominoes will begin falling within the next two weeks per recent PR.
November 15, 2018
"NOUV anticipates having its financial reporting current within the next two weeks."
http://ih.advfn.com/p.php?pid=nmona&article=78698532
under the radar near-term catalyst is...Nouveau Life Pharmaceuticals, (OTC - NOUV).
http://ih.advfn.com/p.php?pid=nmona&article=78727131
US Cannabis Health
Kali recently announced is partnership in a Joint Venture, called US Cannabis Health, to combine its resources and expertise with those of Puration, Inc. (PURA) and Nouveau Life Pharmaceuticals, Inc. (NOUV) to together attract partnerships with major pharmaceutical firms for cannabis pharmaceutical developments. The CEO of North American Cannabis Holdings has recently been named as the CEO of the Joint Venture and a formal announcement is anticipated soon. With both Puration and Nouveau operations in the North Texas region, Kali will also relocate its primary operations to the North Texas region.
https://ih.advfn.com/p.php?pid=nmona&article=78727156
NOUV Joint Venture with EVSV Connection
"Nouveau has recently acquired a cannabis cultivation operation from Puration. In the JV, Nouveau would be tasked with developing a proprietary pharmaceutical grade hemp cultivar. The acquired cannabis cultivation has already initiated efforts toward developing a proprietary, pharmaceutical grade hemp cultivar."
https://finance.yahoo.com/news/kali-inc-announces-us-cannabis-155428738.html
Enviro-Serv Inc To Roll Out 2019 Hemp Farming Services Plan At Southern US Hemp Conference and Expo
"EVSV is bringing its expertise in organic fertilizers and other cultivation services to the industrial hemp farming market. Among other ongoing developments, the company is in conversations to engaged in a joint venture with a cannabis cultivation operation working to develop a proprietary hemp cultivar."
https://ih.advfn.com/p.php?pid=nmona&article=78708901
Another Joint Venture with NOUV...
"...Among other ongoing developments, the company (EVSV) is in conversations to engaged in a joint venture with a cannabis cultivation operation working to develop a proprietary hemp cultivar."
https://ih.advfn.com/p.php?pid=nmona&article=78708901
NOUV plans to keep NOUV and PURA shareholders up to date on the stock dividend process, in addition to updating shareholders on the new post cannabis cultivation business acquisition plans from a new corporate website anticipated to launch next week. With the updated website, NOUV’s communication contact information will also be updated.
NOUV has already made substantial progress toward resolving its current financial reporting delinquency. NOUV anticipates having its financial reporting current within the next two weeks.
https://ih.advfn.com/p.php?pid=nmona&article=78698531
Reminder that NOUV is the backbone to this comglomerate and joint venture. Before any products can be extracted or made, the cannabis must be cultivated.
Formal Declaration Anticipated Tomorrow
To concentrate all efforts on expanding its cannabis sector beverage business, Puration recently spun off its cannabis cultivation business by selling the business to Nouveau Life Pharmaceuticals (NOUV). The two companies are working together to restructure NOUV to grow the cannabis cultivation business. In conjunction with the terms of the spinoff transaction and the aforementioned NOUV restructuring, NOUV plans to convert the $1.2 million note issued to PURA into a sufficient number of shares whereby 1 NOUV share will be distributed in a stock dividend for every five shares of Puration stock. In other words, the stock dividend plans calls for Puration shareholders to receive one share of NOUV common stock for every five shares of Puration stock that they own. A formal declaration of the dividend is anticpated tomorrow.
https://ih.advfn.com/p.php?pid=nmona&article=78688085
now that Sessions is gone, highly possible the next Attorney General will take a more reasonable approach to cannabis being labeled a Schedule 1 drug as resistance against that is mounting nationwide. Just last night, on Election Night, three (3) more States voted for either medical or recreational cannabis legalization for persons 21 years of age and older.
GBHL should market weedweb and get on the cannabis wave.
"highly possible the next Attorney General will take a more reasonable approach to cannabis being labeled a Schedule 1 drug as resistance against that is mounting nationwide. Just last night, on Election Night, three (3) more States voted for either medical or recreational cannabis legalization for persons 21 years of age and older."
https://ih.advfn.com/p.php?pid=nmona&article=78638300
NOUV – Cannabis Cultivation Business & Joint Venture
US Cannabis Health is a joint venture involving Puration, Inc., Kali, Inc., and Nouveau Life Pharmaceuticals, Inc. US Cannabis Health was formed for the development of cannabis pharmaceutical and wellness products. The cannabis pharmaceuticals market is forecasted to reach a $50 billion sales by 2029.
Week of November 5th, 2018
NOUV, PURA, KALY, NCM meeting in Dallas.
Kali and NCM are meeting this week in Dallas to both consummate the acquisition and strategize with Puration, Inc. (PURA) and Nouveau Life Pharmaceuticals, Inc. on the recent formation of a joint venture (JV) company to develop cannabis pharmaceutical products. Kali has partnered with PURA and NOUV to form US Cannabis Health, a JV company formed for the development of cannabis pharmaceutical and wellness products. The cannabis pharmaceuticals market is forecasted to reach a $50 billion sales by 2029.
"Representatives of the three companies plan to meet next week in Dallas, Texas at Puration’s headquarters. Look for more news on the JV following next week’s meetings."
https://finance.yahoo.com/news/kali-inc-announces-us-cannabis-155428738.html
November 02, 2018
SARASOTA, Fla., Nov. 02, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali, Inc. (USOTC: KALY) today published the online presentation included here below to detail the strategy behind the recently announced plans with Puration, Inc. (USOTC: PURA) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) to form a joint venture (JV) company to develop cannabis pharmaceutical products. The cannabis pharmaceutical market is anticipated to reach a value of $50 billion by 2029. Nouveau has recently acquired a cannabis cultivation operation from Puration. In the JV, Nouveau would be tasked with developing a proprietary pharmaceutical grade hemp cultivar. The acquired cannabis cultivation has already initiated efforts toward developing a proprietary, pharmaceutical grade hemp cultivar.
https://finance.yahoo.com/news/kali-inc-announces-us-cannabis-155428738.html
October 29, 2018
"Kali, Inc. (USOTC: KALY) today announced entering into discussions with Puration, Inc. (USOTC: PURA) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) to explore forming a joint venture company between the three to develop cannabis pharmaceutical products...Look for more info on Kali’s plans with NCM Biotech and Puration and Nouveau later this week in a management presentation on the company’s comprehensive post acquisition business plan."
https://finance.yahoo.com/news/kali-inc-enters-discussions-puration-150149527.html
October 4, 2018
"In addition to PURA's plan to file its 2018 Q3 report on or before November 12th, NOUV management plans to bring NOUV current with its reporting requirements in the same time frame."
https://finance.yahoo.com/news/puration-inc-targets-november-15th-125000284.html
NOUV remains to be the backbone to this joint venture. Before any products can be extracted or made, the cannabis must be cultivated. NOUV is in a very, very good position.
“Some feedback has specifically indicated that a number of our candidate pharmaceutical products under development have a greater efficacy potential than GW Pharmaceutical products and candidate products.”
https://finance.yahoo.com/news/kali-inc-present-strategy-entering-133802344.html
If this Joint Venture can produce products with greater efficacy than GW Pharmaceutical, the future is very promising for the three companies involved. GW Pharmaceutical is trading on the NASDAQ (NASDAQ:GWPH). Currently it has attracted attention from big companies such as Constellation Brands, Coca-Cola, Heineken, and others. These are only beverage brands, soon it will attract major top tier pharmaceutical companies as well.
"To streamline and concentrate all its resources on the production of cannabis infused beverages, Puration has recently spun-off its cannabis cultivation operation. The spinoff was affected through the execution of a securities exchange agreement with Nouveau Life Pharmaceuticals, Inc., (NOUV) (“NOUV”). Now that the securities exchange agreement between NOUV and Puration is finalized, NOUV is working to rapidly come current with its financial reports. The first steps leading to the stock dividend distribution are underway, and the combined management teams are committed."
https://www.purationinc.com/cannabisbeveragebusinessplan/
"The company acquired First Choice Nursery last year to establish a 25-greenhouse operation in the first step of a plan to grow the operation to 400 greenhouses. First Choice Nursery began booking its first sales in the first quarter of this year.
First Choice Nursery which has an existing twenty-five greenhouse facility in Texas. The company has the opportunity to expand to an additional 400 irrigated greenhouse pads ready for buildout. Renovations have already begun. Puration has a U.S. Patented Cannabis Extraction process licensed from NCM Biotech. The license of the process to Puration is the first and only license NCM Biotech has executed. R&D with NCM Biotech's patented process has demonstrated a high potential for bringing FDA approved pharmaceutical products to market for the treatment of multiple neurological disorders and cancer.
"I have received doctor feedback from more than one of our research initiatives that extracts coming from NCM Biotech's patented process are superior in purity and quality to any other available cannabis extracts," said Frederick Ferri, CEO and Founder of NCM Biotech. "Some feedback has specifically indicated that a number of our candidate pharmaceutical products under development have a greater efficacy potential than GW Pharmaceutical products and candidate products."
Puration and NCM Biotech plan to expand existing University Research relationships to include a portion of the greenhouse facility being utilized to develop a proprietary strain of CBD. Puration will use proceeds from the balance of the traditional nursery operation to expand the operation into its full 400 greenhouse potential. The operation is located in a region of East Texas well known for nursery operations. Texas has recently legalized medical marijuana and is pending the issuance of its first licenses. Puration intends to transition to marijuana growing overtime in conjunction with the legalization process. In the meantime, Puration anticipates the traditional nursery operations have the potential to expand to as high as $16 million in annual sales. Medical Marijuana sales can be substantially higher."
A major component of having the best cannabis extract is having the best cannabis plants from which to extract cannabinoids. Cannabis cultivation is a natural extension of Puration's long-term development. Being headquartered in Texas, it made sense to take advantage of new medical marijuana laws in Texas. Accordingly, Puration acquired an older conventional nursery operation, First Choice Nursery, and immediately began renovations. Puration is now utilizing the 25-greenhouse facility conventionally and anticipates growing to $1 million in annual sales from conventional nursery operations. First Choice Nursery started booking its first sales since the Puration acquisition in the first quarter of this year. Puration has an option on acquiring another 400 greenhouse pads. Puration is working to secure a medical marijuana cultivation license in Texas with future plans to migrate the conventional nursery operation into a cannabis cultivation operation.
https://finance.yahoo.com/news/puration-cannabis-cultivation-business-takes-131300744.html
Puration's Cannabis Cultivation Foundation
Puration has implemented a long-term cannabis cultivation strategy to navigate the evolving legal environment and ultimately establish a recognized brand name in the cannabis marketplace. Through last year's acquisition of First Choice Nursery, Puration has already set up a 25-greenhouse operation in its home state of Texas where limited medical marijuana legalization has passed. The company is working to establish a university-backed cannabis cultivation research facility within the 25-greenhouse operation. In the meantime, the facility is financed by growing conventional household and landscape plants. It is expected to generate $1 million in revenue this year and self-finance the expansion of the 25-greenhouse operation into as many as 400-greenhouses. Once recreational marijuana is legal either through state or federal law, the Texas facility will be in a leadership position with a robust production facility ready-to-go and a university research backed cultivation process in place.
Canadian Cannabis Farmers Co-Op Business Plan
The acquisition of Canadian Cannabis Farmers Co-Op positions Puration for the estimated $5 billion recreational marijuana market expected to be legalized nationwide in Canada this summer. With the acquisition, Puration now has in-house cultivation experience garnered from the operation of a licensed medical marijuana facility of substantial size. The company plans to apply for a recreational license and anticipates its medical marijuana experience to be of benefit in the recreational license application process. Similar to other Canadian marijuana sector companies such as Canopy Growth Corp. (TWMJF), Aurora Cannabis (ACBFF), Aphria (APHQF), MedReleaf (MEDFF), and OrganiGram Holdings (ORGMF). Puration has plans to build substantial in-house operations. The company has already received interest from investors in backing the construction of facilities for pursuing the Canadian legal marijuana market. However, in addition to building out in-house operations, Puration plans to take its acquired expertise to what it expects to be a robust micro-cultivation and micro-processing market. Health Canada recently announced plans to introduce new micro-cultivation and micro-processing licenses. A micro-cultivation license would be issued to an authorized plant canopy area of less than 200 square meters (2,153 square feet), and a micro-processing license allowed for those processing less than 600 kilograms, or 1,323 pounds, of dried cannabis a year. The legalization of recreational marijuana in Canada also includes individual cultivation for up to four plants. Puration plans to serve the micro-cultivation, micro-processing and home-growers marketplace with products and services necessary for production. By establishing a recognized brand name in cannabis cultivation from its in-house production, Puration expects to leverage its brand name to tap into the more profitable micro-cultivation, micro-processing and home-growers marketplace. To help illustrate the opportunity, consider the micro-brewery and home brewing marketplace in the United States alone. Retail dollar sales for craft micro-brewed beer in the U.S. is approximately $26.0 billion, accounting for more than 23% of the overall $111.4 billion U.S. beer market.
https://finance.yahoo.com/news/puration-presents-cannabis-cultivation-strategy-150000832.html
“Puration had initiated a project to expand its extraction process upstream into cannabis cultivation. Having the best extracts depends not only on the extraction process itself, but also on the quality of the cannabis being extracted. Puration has cultivation operations in the United States and Canada.”
https://www.purationinc.com/extraction
Puration Inc Targets November 15th to Declare 1:5 Cannabis Cultivation Stock Dividend
Kali Inc. Enters Discussions with Puration and Nouveau Life Pharmaceuticals to Enter $50 Billion Cannabis Pharmaceuticals Market
NOUV - Important Notes
"Now that the securities exchange agreement between NOUV and Puration is finalized, NOUV is working to rapidly come current with its financial reports." - https://www.purationinc.com/cannabisbeveragebusinessplan/
"NOUV management plans to bring NOUV current with its reporting requirements in the same time frame...on or before November 12th"
https://finance.yahoo.com/news/puration-inc-targets-november-15th-125000284.html
"Management has shown no interest in reverse splits"
Nouveau Life Pharmaceuticals (USOTC: NOUV) ($0.0003) - NOUV has recently acquired a cannabis cultivation operation from cannabis industry juggernaut Puration, Inc. (USOTC: PURA). The company is issuing a stock dividend to the shareholders of PURA. The dividend, set to be declared on the 15th of November, and the overall business relationship with PURA stands to potentially drive NOUV into the double digits between now and the 15th of November...Management has shown no interest in reverse splits and seems content with working in the sub penny range continuing to incubate new cannabis sector enterprises and giving shareholders the opportunity to enjoy one triple zero to double zero run after another.
https://ih.advfn.com/p.php?pid=nmona&article=78569240
"The Amazon of Cannabis"
"The vision for the company is to become the Amazon of cannabis."
https://www.advfn.com/p.php?pid=nmona&article=77705634
NOUV, PURA, KALY, NCM meeting in Dallas.
Kali and NCM are meeting this week in Dallas to both consummate the acquisition and strategize with Puration, Inc. (PURA) and Nouveau Life Pharmaceuticals, Inc. on the recent formation of a joint venture (JV) company to develop cannabis pharmaceutical products. Kali has partnered with PURA and NOUV to form US Cannabis Health, a JV company formed for the development of cannabis pharmaceutical and wellness products. The cannabis pharmaceuticals market is forecasted to reach a $50 billion sales by 2029.
https://ih.advfn.com/p.php?pid=nmona&article=78623781
Nouveau Life Pharmaceuticals, Inc (NOUV) – Cannabis Cultivation Business & Joint Venture
US Cannabis Health is a joint venture involving Puration, Inc., Kali, Inc., and Nouveau Life Pharmaceuticals, Inc. US Cannabis Health was formed for the development of cannabis pharmaceutical and wellness products. The cannabis pharmaceuticals market is forecasted to reach a $50 billion sales by 2029.
Week of November 5th, 2018
"Representatives of the three companies plan to meet next week in Dallas, Texas at Puration’s headquarters. Look for more news on the JV following next week’s meetings."
https://finance.yahoo.com/news/kali-inc-announces-us-cannabis-155428738.html
November 02, 2018
SARASOTA, Fla., Nov. 02, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali, Inc. (USOTC: KALY) today published the online presentation included here below to detail the strategy behind the recently announced plans with Puration, Inc. (USOTC: PURA) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) to form a joint venture (JV) company to develop cannabis pharmaceutical products. The cannabis pharmaceutical market is anticipated to reach a value of $50 billion by 2029. Nouveau has recently acquired a cannabis cultivation operation from Puration. In the JV, Nouveau would be tasked with developing a proprietary pharmaceutical grade hemp cultivar. The acquired cannabis cultivation has already initiated efforts toward developing a proprietary, pharmaceutical grade hemp cultivar.
https://finance.yahoo.com/news/kali-inc-announces-us-cannabis-155428738.html
October 29, 2018
"Kali, Inc. (USOTC: KALY) today announced entering into discussions with Puration, Inc. (USOTC: PURA) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) to explore forming a joint venture company between the three to develop cannabis pharmaceutical products...Look for more info on Kali’s plans with NCM Biotech and Puration and Nouveau later this week in a management presentation on the company’s comprehensive post acquisition business plan."
https://finance.yahoo.com/news/kali-inc-enters-discussions-puration-150149527.html
October 4, 2018
"In addition to PURA's plan to file its 2018 Q3 report on or before November 12th, NOUV management plans to bring NOUV current with its reporting requirements in the same time frame."
https://finance.yahoo.com/news/puration-inc-targets-november-15th-125000284.html
"Representatives of the three companies plan to meet next week in Dallas, Texas at Puration’s headquarters."
https://finance.yahoo.com/news/kali-inc-present-strategy-entering-133802344.html
NOUV remains to be the backbone to this joint venture. Before any products can be extracted or made, the cannabis must be cultivated. NOUV is in a very, very good position.
“Some feedback has specifically indicated that a number of our candidate pharmaceutical products under development have a greater efficacy potential than GW Pharmaceutical products and candidate products.”
https://finance.yahoo.com/news/kali-inc-present-strategy-entering-133802344.html
If this Joint Venture can produce products with greater efficacy than GW Pharmaceutical, the future is very promising for the three companies involved. GW Pharmaceutical is trading on the NASDAQ (NASDAQ:GWPH). Currently it has attracted attention from big companies such as Constellation Brands, Coca-Cola, Heineken, and others. These are only beverage brands, soon it will attract major top tier pharmaceutical companies as well.
"To streamline and concentrate all its resources on the production of cannabis infused beverages, Puration has recently spun-off its cannabis cultivation operation. The spinoff was affected through the execution of a securities exchange agreement with Nouveau Life Pharmaceuticals, Inc., (NOUV) (“NOUV”). Now that the securities exchange agreement between NOUV and Puration is finalized, NOUV is working to rapidly come current with its financial reports. The first steps leading to the stock dividend distribution are underway, and the combined management teams are committed."
https://www.purationinc.com/cannabisbeveragebusinessplan/
"The company acquired First Choice Nursery last year to establish a 25-greenhouse operation in the first step of a plan to grow the operation to 400 greenhouses. First Choice Nursery began booking its first sales in the first quarter of this year.
First Choice Nursery which has an existing twenty-five greenhouse facility in Texas. The company has the opportunity to expand to an additional 400 irrigated greenhouse pads ready for buildout. Renovations have already begun. Puration has a U.S. Patented Cannabis Extraction process licensed from NCM Biotech. The license of the process to Puration is the first and only license NCM Biotech has executed. R&D with NCM Biotech's patented process has demonstrated a high potential for bringing FDA approved pharmaceutical products to market for the treatment of multiple neurological disorders and cancer.
"I have received doctor feedback from more than one of our research initiatives that extracts coming from NCM Biotech's patented process are superior in purity and quality to any other available cannabis extracts," said Frederick Ferri, CEO and Founder of NCM Biotech. "Some feedback has specifically indicated that a number of our candidate pharmaceutical products under development have a greater efficacy potential than GW Pharmaceutical products and candidate products."
Puration and NCM Biotech plan to expand existing University Research relationships to include a portion of the greenhouse facility being utilized to develop a proprietary strain of CBD. Puration will use proceeds from the balance of the traditional nursery operation to expand the operation into its full 400 greenhouse potential. The operation is located in a region of East Texas well known for nursery operations. Texas has recently legalized medical marijuana and is pending the issuance of its first licenses. Puration intends to transition to marijuana growing overtime in conjunction with the legalization process. In the meantime, Puration anticipates the traditional nursery operations have the potential to expand to as high as $16 million in annual sales. Medical Marijuana sales can be substantially higher."
A major component of having the best cannabis extract is having the best cannabis plants from which to extract cannabinoids. Cannabis cultivation is a natural extension of Puration's long-term development. Being headquartered in Texas, it made sense to take advantage of new medical marijuana laws in Texas. Accordingly, Puration acquired an older conventional nursery operation, First Choice Nursery, and immediately began renovations. Puration is now utilizing the 25-greenhouse facility conventionally and anticipates growing to $1 million in annual sales from conventional nursery operations. First Choice Nursery started booking its first sales since the Puration acquisition in the first quarter of this year. Puration has an option on acquiring another 400 greenhouse pads. Puration is working to secure a medical marijuana cultivation license in Texas with future plans to migrate the conventional nursery operation into a cannabis cultivation operation.
https://finance.yahoo.com/news/puration-cannabis-cultivation-business-takes-131300744.html
Puration's Cannabis Cultivation Foundation
Puration has implemented a long-term cannabis cultivation strategy to navigate the evolving legal environment and ultimately establish a recognized brand name in the cannabis marketplace. Through last year's acquisition of First Choice Nursery, Puration has already set up a 25-greenhouse operation in its home state of Texas where limited medical marijuana legalization has passed. The company is working to establish a university-backed cannabis cultivation research facility within the 25-greenhouse operation. In the meantime, the facility is financed by growing conventional household and landscape plants. It is expected to generate $1 million in revenue this year and self-finance the expansion of the 25-greenhouse operation into as many as 400-greenhouses. Once recreational marijuana is legal either through state or federal law, the Texas facility will be in a leadership position with a robust production facility ready-to-go and a university research backed cultivation process in place.
Canadian Cannabis Farmers Co-Op Business Plan
The acquisition of Canadian Cannabis Farmers Co-Op positions Puration for the estimated $5 billion recreational marijuana market expected to be legalized nationwide in Canada this summer. With the acquisition, Puration now has in-house cultivation experience garnered from the operation of a licensed medical marijuana facility of substantial size. The company plans to apply for a recreational license and anticipates its medical marijuana experience to be of benefit in the recreational license application process. Similar to other Canadian marijuana sector companies such as Canopy Growth Corp. (TWMJF), Aurora Cannabis (ACBFF), Aphria (APHQF), MedReleaf (MEDFF), and OrganiGram Holdings (ORGMF). Puration has plans to build substantial in-house operations. The company has already received interest from investors in backing the construction of facilities for pursuing the Canadian legal marijuana market. However, in addition to building out in-house operations, Puration plans to take its acquired expertise to what it expects to be a robust micro-cultivation and micro-processing market. Health Canada recently announced plans to introduce new micro-cultivation and micro-processing licenses. A micro-cultivation license would be issued to an authorized plant canopy area of less than 200 square meters (2,153 square feet), and a micro-processing license allowed for those processing less than 600 kilograms, or 1,323 pounds, of dried cannabis a year. The legalization of recreational marijuana in Canada also includes individual cultivation for up to four plants. Puration plans to serve the micro-cultivation, micro-processing and home-growers marketplace with products and services necessary for production. By establishing a recognized brand name in cannabis cultivation from its in-house production, Puration expects to leverage its brand name to tap into the more profitable micro-cultivation, micro-processing and home-growers marketplace. To help illustrate the opportunity, consider the micro-brewery and home brewing marketplace in the United States alone. Retail dollar sales for craft micro-brewed beer in the U.S. is approximately $26.0 billion, accounting for more than 23% of the overall $111.4 billion U.S. beer market.
https://finance.yahoo.com/news/puration-presents-cannabis-cultivation-strategy-150000832.html
“Puration had initiated a project to expand its extraction process upstream into cannabis cultivation. Having the best extracts depends not only on the extraction process itself, but also on the quality of the cannabis being extracted. Puration has cultivation operations in the United States and Canada.”
https://www.purationinc.com/extraction
Puration Inc Targets November 15th to Declare 1:5 Cannabis Cultivation Stock Dividend
Kali Inc. Enters Discussions with Puration and Nouveau Life Pharmaceuticals to Enter $50 Billion Cannabis Pharmaceuticals Market
NOUV - Important Notes
"Now that the securities exchange agreement between NOUV and Puration is finalized, NOUV is working to rapidly come current with its financial reports." - https://www.purationinc.com/cannabisbeveragebusinessplan/
"NOUV management plans to bring NOUV current with its reporting requirements in the same time frame...on or before November 12th"
https://finance.yahoo.com/news/puration-inc-targets-november-15th-125000284.html
"Management has shown no interest in reverse splits"
Nouveau Life Pharmaceuticals (USOTC: NOUV) ($0.0003) - NOUV has recently acquired a cannabis cultivation operation from cannabis industry juggernaut Puration, Inc. (USOTC: PURA). The company is issuing a stock dividend to the shareholders of PURA. The dividend, set to be declared on the 15th of November, and the overall business relationship with PURA stands to potentially drive NOUV into the double digits between now and the 15th of November...Management has shown no interest in reverse splits and seems content with working in the sub penny range continuing to incubate new cannabis sector enterprises and giving shareholders the opportunity to enjoy one triple zero to double zero run after another.
https://ih.advfn.com/p.php?pid=nmona&article=78569240
"Nouveau has recently acquired a cannabis cultivation operation from Puration. In the JV, Nouveau would be tasked with developing a proprietary pharmaceutical grade hemp cultivar. The acquired cannabis cultivation has already initiated efforts toward developing a proprietary, pharmaceutical grade hemp cultivar."
https://ih.advfn.com/p.php?pid=nmona&article=78603369
NEWS - Kali Inc Announces US Cannabis Health JV With Puration and Nouveau Life Pharmaceuticals
https://ih.advfn.com/p.php?pid=nmona&article=78603369
Cannabis Cultivation Business - Nouveau Life Pharmaceuticals,Inc.
"To streamline and concentrate all its resources on the production of cannabis infused beverages, Puration has recently spun-off its cannabis cultivation operation. The spinoff was affected through the execution of a securities exchange agreement with Nouveau Life Pharmaceuticals, Inc., (NOUV) (“NOUV”). Now that the securities exchange agreement between NOUV and Puration is finalized, NOUV is working to rapidly come current with its financial reports. The first steps leading to the stock dividend distribution are underway, and the combined management teams are committed."
https://www.purationinc.com/cannabisbeveragebusinessplan/
"The company acquired First Choice Nursery last year to establish a 25-greenhouse operation in the first step of a plan to grow the operation to 400 greenhouses. First Choice Nursery began booking its first sales in the first quarter of this year.
First Choice Nursery which has an existing twenty-five greenhouse facility in Texas. The company has the opportunity to expand to an additional 400 irrigated greenhouse pads ready for buildout. Renovations have already begun. Puration has a U.S. Patented Cannabis Extraction process licensed from NCM Biotech. The license of the process to Puration is the first and only license NCM Biotech has executed. R&D with NCM Biotech's patented process has demonstrated a high potential for bringing FDA approved pharmaceutical products to market for the treatment of multiple neurological disorders and cancer.
"I have received doctor feedback from more than one of our research initiatives that extracts coming from NCM Biotech's patented process are superior in purity and quality to any other available cannabis extracts," said Frederick Ferri, CEO and Founder of NCM Biotech. "Some feedback has specifically indicated that a number of our candidate pharmaceutical products under development have a greater efficacy potential than GW Pharmaceutical products and candidate products."
Puration and NCM Biotech plan to expand existing University Research relationships to include a portion of the greenhouse facility being utilized to develop a proprietary strain of CBD. Puration will use proceeds from the balance of the traditional nursery operation to expand the operation into its full 400 greenhouse potential. The operation is located in a region of East Texas well known for nursery operations. Texas has recently legalized medical marijuana and is pending the issuance of its first licenses. Puration intends to transition to marijuana growing overtime in conjunction with the legalization process. In the meantime, Puration anticipates the traditional nursery operations have the potential to expand to as high as $16 million in annual sales. Medical Marijuana sales can be substantially higher."
A major component of having the best cannabis extract is having the best cannabis plants from which to extract cannabinoids. Cannabis cultivation is a natural extension of Puration's long-term development. Being headquartered in Texas, it made sense to take advantage of new medical marijuana laws in Texas. Accordingly, Puration acquired an older conventional nursery operation, First Choice Nursery, and immediately began renovations. Puration is now utilizing the 25-greenhouse facility conventionally and anticipates growing to $1 million in annual sales from conventional nursery operations. First Choice Nursery started booking its first sales since the Puration acquisition in the first quarter of this year. Puration has an option on acquiring another 400 greenhouse pads. Puration is working to secure a medical marijuana cultivation license in Texas with future plans to migrate the conventional nursery operation into a cannabis cultivation operation.
https://finance.yahoo.com/news/puration-cannabis-cultivation-business-takes-131300744.html
Puration's Cannabis Cultivation Foundation
Puration has implemented a long-term cannabis cultivation strategy to navigate the evolving legal environment and ultimately establish a recognized brand name in the cannabis marketplace. Through last year's acquisition of First Choice Nursery, Puration has already set up a 25-greenhouse operation in its home state of Texas where limited medical marijuana legalization has passed. The company is working to establish a university-backed cannabis cultivation research facility within the 25-greenhouse operation. In the meantime, the facility is financed by growing conventional household and landscape plants. It is expected to generate $1 million in revenue this year and self-finance the expansion of the 25-greenhouse operation into as many as 400-greenhouses. Once recreational marijuana is legal either through state or federal law, the Texas facility will be in a leadership position with a robust production facility ready-to-go and a university research backed cultivation process in place.
Canadian Cannabis Farmers Co-Op Business Plan
The acquisition of Canadian Cannabis Farmers Co-Op positions Puration for the estimated $5 billion recreational marijuana market expected to be legalized nationwide in Canada this summer. With the acquisition, Puration now has in-house cultivation experience garnered from the operation of a licensed medical marijuana facility of substantial size. The company plans to apply for a recreational license and anticipates its medical marijuana experience to be of benefit in the recreational license application process. Similar to other Canadian marijuana sector companies such as Canopy Growth Corp. (TWMJF), Aurora Cannabis (ACBFF), Aphria (APHQF), MedReleaf (MEDFF), and OrganiGram Holdings (ORGMF). Puration has plans to build substantial in-house operations. The company has already received interest from investors in backing the construction of facilities for pursuing the Canadian legal marijuana market. However, in addition to building out in-house operations, Puration plans to take its acquired expertise to what it expects to be a robust micro-cultivation and micro-processing market. Health Canada recently announced plans to introduce new micro-cultivation and micro-processing licenses. A micro-cultivation license would be issued to an authorized plant canopy area of less than 200 square meters (2,153 square feet), and a micro-processing license allowed for those processing less than 600 kilograms, or 1,323 pounds, of dried cannabis a year. The legalization of recreational marijuana in Canada also includes individual cultivation for up to four plants. Puration plans to serve the micro-cultivation, micro-processing and home-growers marketplace with products and services necessary for production. By establishing a recognized brand name in cannabis cultivation from its in-house production, Puration expects to leverage its brand name to tap into the more profitable micro-cultivation, micro-processing and home-growers marketplace. To help illustrate the opportunity, consider the micro-brewery and home brewing marketplace in the United States alone. Retail dollar sales for craft micro-brewed beer in the U.S. is approximately $26.0 billion, accounting for more than 23% of the overall $111.4 billion U.S. beer market.
https://finance.yahoo.com/news/puration-presents-cannabis-cultivation-strategy-150000832.html
“Puration had initiated a project to expand its extraction process upstream into cannabis cultivation. Having the best extracts depends not only on the extraction process itself, but also on the quality of the cannabis being extracted. Puration has cultivation operations in the United States and Canada.”
https://www.purationinc.com/extraction
Puration Inc Targets November 15th to Declare 1:5 Cannabis Cultivation Stock Dividend
Kali Inc. Enters Discussions with Puration and Nouveau Life Pharmaceuticals to Enter $50 Billion Cannabis Pharmaceuticals Market
NOUV - Important Notes
"Now that the securities exchange agreement between NOUV and Puration is finalized, NOUV is working to rapidly come current with its financial reports." - https://www.purationinc.com/cannabisbeveragebusinessplan/
"NOUV management plans to bring NOUV current with its reporting requirements in the same time frame...on or before November 12th"
https://finance.yahoo.com/news/puration-inc-targets-november-15th-125000284.html
"Management has shown no interest in reverse splits"
Nouveau Life Pharmaceuticals (USOTC: NOUV) ($0.0003) - NOUV has recently acquired a cannabis cultivation operation from cannabis industry juggernaut Puration, Inc. (USOTC: PURA). The company is issuing a stock dividend to the shareholders of PURA. The dividend, set to be declared on the 15th of November, and the overall business relationship with PURA stands to potentially drive NOUV into the double digits between now and the 15th of November...Management has shown no interest in reverse splits and seems content with working in the sub penny range continuing to incubate new cannabis sector enterprises and giving shareholders the opportunity to enjoy one triple zero to double zero run after another.
https://ih.advfn.com/p.php?pid=nmona&article=78569240
October 29, 2018
"Kali, Inc. (USOTC: KALY) today announced entering into discussions with Puration, Inc. (USOTC: PURA) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) to explore forming a joint venture company between the three to develop cannabis pharmaceutical products...Look for more info on Kali’s plans with NCM Biotech and Puration and Nouveau later this week in a management presentation on the company’s comprehensive post acquisition business plan."
https://finance.yahoo.com/news/kali-inc-enters-discussions-puration-150149527.html
October 4, 2018
"In addition to PURA's plan to file its 2018 Q3 report on or before November 12th, NOUV management plans to bring NOUV current with its reporting requirements in the same time frame."
https://finance.yahoo.com/news/puration-inc-targets-november-15th-125000284.html
"Representatives of the three companies plan to meet next week in Dallas, Texas at Puration’s headquarters."
https://finance.yahoo.com/news/kali-inc-present-strategy-entering-133802344.html
NOUV remains to be the backbone to this joint venture. Before any products can be extracted or made, the cannabis must be cultivated. NOUV is in a very, very good position.
“Some feedback has specifically indicated that a number of our candidate pharmaceutical products under development have a greater efficacy potential than GW Pharmaceutical products and candidate products.”
https://finance.yahoo.com/news/kali-inc-present-strategy-entering-133802344.html
If this Joint Venture can produce products with greater efficacy than GW Pharmaceutical, the future is very promising for the three companies involved. GW Pharmaceutical is trading on the NASDAQ (NASDAQ:GWPH). Currently it has attracted attention from big companies such as Constellation Brands, Coca-Cola, Heineken, and others. These are only beverage brands, soon it will attract major top tier pharmaceutical companies as well.
it is only the poster's opinion, NOUV will move as high as there is interest. IMHO, NOUV will test 0.01 before end of year. there are a lot of developments with this joint venture and the backbone (cannabis cultivation to produce infused beverages, medicine, and recreational use for the three companies here in the U.S.A. and Canada) to this business plan.